| 0.7 |
2.0 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 0.3 |
0.7 |
GO:1904139 |
microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
| 0.3 |
1.0 |
GO:2000852 |
regulation of corticosterone secretion(GO:2000852) |
| 0.3 |
1.3 |
GO:0038145 |
macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.3 |
1.5 |
GO:2000065 |
negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
| 0.3 |
2.0 |
GO:0009449 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.3 |
0.8 |
GO:0010814 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.2 |
0.6 |
GO:0002586 |
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.2 |
0.5 |
GO:0014738 |
regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
| 0.2 |
0.5 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.1 |
1.3 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
| 0.1 |
1.3 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.1 |
0.9 |
GO:0070458 |
detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.1 |
2.3 |
GO:0060236 |
regulation of mitotic spindle organization(GO:0060236) |
| 0.1 |
2.3 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 0.1 |
1.2 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.1 |
0.2 |
GO:0071603 |
endothelial cell-cell adhesion(GO:0071603) |
| 0.1 |
0.3 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.1 |
0.3 |
GO:0051342 |
regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.1 |
0.5 |
GO:0000098 |
sulfur amino acid catabolic process(GO:0000098) |
| 0.1 |
0.6 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.1 |
0.4 |
GO:0071475 |
cellular hyperosmotic salinity response(GO:0071475) |
| 0.1 |
0.6 |
GO:0009786 |
regulation of asymmetric cell division(GO:0009786) |
| 0.1 |
0.6 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.1 |
0.7 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.1 |
0.7 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 0.1 |
1.2 |
GO:0090136 |
epithelial cell-cell adhesion(GO:0090136) |
| 0.1 |
0.2 |
GO:0046077 |
dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
| 0.1 |
0.2 |
GO:0019478 |
D-amino acid catabolic process(GO:0019478) |
| 0.1 |
0.6 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.1 |
0.4 |
GO:0010359 |
regulation of anion channel activity(GO:0010359) |
| 0.1 |
0.4 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.1 |
0.5 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.1 |
0.4 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.1 |
0.2 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.1 |
1.0 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.1 |
0.2 |
GO:0002678 |
positive regulation of chronic inflammatory response(GO:0002678) positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.1 |
0.3 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.1 |
0.3 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.1 |
0.6 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
| 0.1 |
0.3 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 0.1 |
0.5 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.1 |
0.2 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.1 |
0.5 |
GO:0071907 |
determination of digestive tract left/right asymmetry(GO:0071907) |
| 0.1 |
0.3 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.1 |
0.2 |
GO:1904569 |
regulation of selenocysteine incorporation(GO:1904569) |
| 0.1 |
0.6 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.1 |
0.4 |
GO:2000002 |
negative regulation of DNA damage checkpoint(GO:2000002) |
| 0.1 |
0.3 |
GO:0001302 |
replicative cell aging(GO:0001302) |
| 0.1 |
0.4 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.1 |
0.4 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) benzene-containing compound metabolic process(GO:0042537) |
| 0.1 |
0.2 |
GO:2001045 |
negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.1 |
0.2 |
GO:0044650 |
virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
| 0.1 |
0.3 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.1 |
0.4 |
GO:0060923 |
cardiac muscle cell fate commitment(GO:0060923) |
| 0.0 |
0.3 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.0 |
0.1 |
GO:0070366 |
regulation of hepatocyte differentiation(GO:0070366) |
| 0.0 |
1.4 |
GO:0043330 |
response to exogenous dsRNA(GO:0043330) |
| 0.0 |
0.7 |
GO:0045187 |
regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
| 0.0 |
0.5 |
GO:0042415 |
norepinephrine metabolic process(GO:0042415) |
| 0.0 |
0.3 |
GO:0002544 |
chronic inflammatory response(GO:0002544) |
| 0.0 |
0.3 |
GO:0019254 |
carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.0 |
0.6 |
GO:0032793 |
positive regulation of CREB transcription factor activity(GO:0032793) membrane hyperpolarization(GO:0060081) |
| 0.0 |
0.6 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.0 |
1.0 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.0 |
0.4 |
GO:0018065 |
protein-cofactor linkage(GO:0018065) |
| 0.0 |
0.3 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.0 |
0.2 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.0 |
0.5 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.0 |
1.4 |
GO:1902476 |
chloride transmembrane transport(GO:1902476) |
| 0.0 |
0.1 |
GO:0097211 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.0 |
0.1 |
GO:0006490 |
oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.0 |
0.1 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.0 |
0.7 |
GO:0033194 |
response to hydroperoxide(GO:0033194) |
| 0.0 |
2.0 |
GO:0035019 |
somatic stem cell population maintenance(GO:0035019) |
| 0.0 |
0.1 |
GO:1904995 |
negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
| 0.0 |
0.1 |
GO:0070625 |
zymogen granule exocytosis(GO:0070625) |
| 0.0 |
0.2 |
GO:0060718 |
chorionic trophoblast cell differentiation(GO:0060718) |
| 0.0 |
0.6 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.0 |
0.1 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.0 |
0.2 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.0 |
0.2 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.0 |
0.2 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.0 |
0.4 |
GO:0036093 |
germ cell proliferation(GO:0036093) |
| 0.0 |
0.2 |
GO:0015808 |
L-alanine transport(GO:0015808) |
| 0.0 |
0.2 |
GO:0070092 |
glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
| 0.0 |
0.3 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.0 |
0.8 |
GO:0006911 |
phagocytosis, engulfment(GO:0006911) |
| 0.0 |
0.4 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.0 |
1.2 |
GO:2000134 |
negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.0 |
0.3 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.0 |
0.1 |
GO:0090245 |
axis elongation involved in somitogenesis(GO:0090245) |
| 0.0 |
0.1 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.0 |
0.3 |
GO:0031987 |
locomotion involved in locomotory behavior(GO:0031987) |
| 0.0 |
0.4 |
GO:0006515 |
misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
| 0.0 |
1.1 |
GO:0007019 |
microtubule depolymerization(GO:0007019) |
| 0.0 |
0.2 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.0 |
0.3 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.0 |
0.2 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.0 |
0.7 |
GO:0000266 |
mitochondrial fission(GO:0000266) |
| 0.0 |
0.5 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.0 |
0.1 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.0 |
0.1 |
GO:0071544 |
diphosphoinositol polyphosphate metabolic process(GO:0071543) diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 0.0 |
0.1 |
GO:0072429 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.0 |
0.7 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.0 |
1.2 |
GO:0007127 |
meiosis I(GO:0007127) |
| 0.0 |
0.6 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.0 |
0.3 |
GO:0071480 |
cellular response to gamma radiation(GO:0071480) |
| 0.0 |
0.3 |
GO:1904355 |
positive regulation of telomere capping(GO:1904355) |
| 0.0 |
0.3 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
| 0.0 |
0.3 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.0 |
0.2 |
GO:0060068 |
negative regulation of toll-like receptor signaling pathway(GO:0034122) vagina development(GO:0060068) |
| 0.0 |
0.6 |
GO:0045739 |
positive regulation of DNA repair(GO:0045739) |
| 0.0 |
0.1 |
GO:0036035 |
osteoclast development(GO:0036035) |
| 0.0 |
0.0 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 0.0 |
0.2 |
GO:0010667 |
negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.0 |
0.4 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.0 |
0.6 |
GO:0035307 |
positive regulation of protein dephosphorylation(GO:0035307) |
| 0.0 |
0.1 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.0 |
1.2 |
GO:0050772 |
positive regulation of axonogenesis(GO:0050772) |
| 0.0 |
0.4 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.0 |
0.4 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.0 |
0.1 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.0 |
0.1 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.0 |
0.1 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
